---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-015819"
form_type: "8-K"
ticker: "MED"
cik: "0000910329"
company_name: "MEDIFAST INC"
filed_at: "2022-06-01T23:59:59+00:00"
generated_at: "2026-06-25T05:42:49.803261+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Medifast launches $100M accelerated share repurchase program

## Summary
- Entered ASR with JPMorgan to repurchase $100M of common stock.
- Initial delivery of ~480,000 shares; final settlement expected in Q3 2022.
- Repurchase represents ~600,000 shares at May 31 close, about 5% of fully diluted stock.
- Funded through available cash and borrowings under existing credit facility.
- Approximately 1.4M shares remain available under current repurchase authorization.

## SEC filing metadata
- accession: 0001628280-22-015819
- form_type: 8-K
- ticker: MED
- cik: 0000910329
- company_name: MEDIFAST INC
- filed_at: 2022-06-01T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/910329/000162828022015819/0001628280-22-015819-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/910329/000162828022015819/med-20220601.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-015819
- JSON: https://secwatch.observer/filing/0001628280-22-015819.json
- Plain text: https://secwatch.observer/filing/0001628280-22-015819.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.